Diagnosis of leptomeningeal disease in diffuse large B-cell lymphomas of the central nervous system by flow cytometry and cytopathology

European Journal of Haematology

Volumn 85, Issue 6, 2010, Pages 520-528

  Schroers, Roland ^a   Baraniskin, Alexander ^a   Heute, Christoph ^a   Vorgerd, Matthias ^a   Brunn, Anna ^b   Kuhnhenn, Jan ^a   Kowoll, Annika ^a   Alekseyev, Andriy ^a   Schmiegel, Wolff ^a   Schlegel, Uwe ^a   Deckert, Martina ^b   Pels, Hendrik ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Central nervous system; Cerebrospinal fluid; Cytopathology; Flow cytometry; Lymphoma

Indexed keywords

GADOLINIUM;

ADULT; AGED; ARTICLE; BRAIN LYMPHOMA; CARCINOMATOUS MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CYTOPATHOLOGY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; LYMPHOMA CELL; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY TUMOR; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MENINGEAL NEOPLASMS; MIDDLE AGED;

EID: 78349295247     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2010.01516.x     Document Type: Article

References (23)

1. Ney DE, Deangelis LM. Management of Central Nervous System Lymphoma. In: Armitage JO, Mauch PM, Harris NL, Coiffier B, Dalla Favera R, editors. Non-Hodgkin Lymphomas. Philadelphia: Lippincott Willilams & Wilkins, 2010:527-39.
2. Pels H, Schlegel U. Primary central nervous system lymphoma. Curr Treat Options Neurol 2006;8:346-57.
3. Pels H, Schmidt-Wolf IG, Glasmacher A, et al. Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 2003;21:4489-95.
4. Abrey LE, Batchelor TT, Ferreri AJ, et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 2005;23:5034-43.
5. Gleissner B, Siehl J, Korfel A, Reinhardt R, Thiel E. CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes. Neurology 2002;58:390-6.
6. Fischer L, Martus P, Weller M, et al. Meningeal dissemination in primary CNS lymphoma: prospective evaluation of 282 patients. Neurology 2008;71:1102-8.
7. Hegde U, Filie A, Little RF, et al. High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood 2005;105: 496-502.
8. Dux R, Kindler-Rohrborn A, Annas M, Faustmann P, Lennartz K, Zimmermann CW. A standardized protocol for flow cytometric analysis of cells isolated from cerebrospinal fluid. J Neurol Sci 1994;121:74-8.
9. French CA, Dorfman DM, Shaheen G, Cibas ES. Diagnosing lymphoproliferative disorders involving the cerebrospinal fluid: increased sensitivity using flow cytometric analysis. Diagn Cytopathol 2000;23:369-74.
10. Finn WG, Peterson LC, James C, Goolsby CL. Enhanced detection of malignant lymphoma in cerebrospinal fluid by multiparameter flow cytometry. Am J Clin Pathol 1998;110:341-6.
11. Roma AA, Garcia A, Avagnina A, Rescia C, Elsner B. Lymphoid and myeloid neoplasms involving cerebrospinal fluid: comparison of morphologic examination and immunophenotyping by flow cytometry. Diagn Cytopathol 2002;27:271-5.
12. Subira D, Castanon S, Aceituno E, Hernandez J, Jimenez-Garofano C, Jimenez A, Jimenez AM, Roman A, Orfao A. Flow cytometric analysis of cerebrospinal fluid samples and its usefulness in routine clinical practice. Am J Clin Pathol 2002;117:952-8.
13. Nowakowski GS, Call TG, Morice WG, Kurtin PJ, Cook RJ, Zent CS. Clinical significance of monoclonal B cells in cerebrospinal fluid. Cytometry B Clin Cytom 2005;63:23-7.
14. Schinstine M, Filie AC, Wilson W, Stetler-Stevenson M, Abati A. Detection of malignant hematopoietic cells in cerebral spinal fluid previously diagnosed as atypical or suspicious. Cancer 2006;108:157-62.
15. Bromberg JE, Breems DA, Kraan J, Bikker G, Van Der HB, Smitt PS, Van Den Bent MJ, Van't Veer M, Gratama JW. CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies. Neurology 2007;68:1674-9.
16. Quijano S, Lopez A, Manuel SJ, et al. Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry. J Clin Oncol 2009;27:1462-9.
17. Schroers R, Huang XF, Hammer J, Zhang J, Chen SY. Identification of HLA DR7-restricted epitopes from human telomerase reverse transcriptase recognized by CD4+ T-helper cells. Cancer Res 2002;62:2600-5.
18. Schroers R, Griesinger F, Trumper L, Haase D, Kulle B, Klein-Hitpass L, Sellmann L, Duhrsen U, Durig J. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia 2005;19:708-8.
19. Schroers R, Baraniskin A, Heute C, Kuhnhenn J, Alekseyev A, Schmiegel W, Schlegel U, Pels HJ. Detection of free immunoglobulin light chains in cerebrospinal fluids of patients with central nervous system lymphomas. Eur J Haematol 2010;85:236-42.
20. Ferreri AJ, Reni M, Pasini F, et al. A multicenter study of treatment of primary CNS lymphoma. Neurology 2002;58:1513-20.
21. Balmaceda C, Gaynor JJ, Sun M, Gluck JT, Deangelis LM. Leptomeningeal tumor in primary central nervous system lymphoma: recognition, significance, and implications. Ann Neurol 1995;38:202-9.
22. Kiewe P, Fischer L, Martus P, Thiel E, Korfel A. Meningeal dissemination in primary CNS lymphoma: diagnosis, treatment, and survival in a large monocenter cohort. Neuro Oncol 2010;12:409-17.
23. Subira D, Gorgolas M, Castanon S, Serrano C, Roman A, Rivas F, Tomas JF. Advantages of flow cytometry immunophenotyping for the diagnosis of central nervous system non-Hodgkin's lymphoma in AIDS patients. HIV Med 2005;6:21-6.